Genesis Topical Spray, 8 oz

Genesis Topical Spray, 8 oz

Sold ONLY to licensed veterinarians and pharmacies. Submit license if not already on file. Fax :: 800-640-3274
Licensed Professional Price: $29.56
Copy of License Required [No Prescriptions Please]

Product Code: 14064


Genesis Topical Spray for Dogs

Canine Allergic Dermatitis Treatment

Genesis Topical Spray is a topical anti-inflammatory spray containing a ultra-low dose of triamcinolone acetonide 0.015%, a steroid proven as effective as oral prednisone and prednisolone. Unlike oral steroids to controll allergic dermatitis in dogs, Genesis Spray goes directly to the skin and does not pass through the stomach, intestines, liver or circulatory system.
  • First topical spray as effective for flea allergic dermatitis as prednisone
  • Controls pruritis ( itching) associated with atopy, unspecified allergic dermatitis, flea allergy and food allergy in dogs
  • Contains no dyes or fragrance For topical use in dogs only
Active Ingredients:
Genesis Topical Spray contains 0.015% triamcinolone acetonide for dermatologic use.

Each mL of Genesis Topical Spray contains 0.15 mg triamcinolone acetonide in an aqueous solution containing propylene glycol, specially denatured alcohol, and DMDM hydantoin.

Dosage and Administration:

Apply sufficient pump sprays to uniformly and thoroughly wet the affected areas while avoiding run-off of excess product. Avoid getting the spray in dog's eyes.

Genesis Topical Spray should be administered twice daily for seven days, once daily for the next seven days, then every other day for an additional 14 days (28 days total).

To avoid overdosing the product, use the following table to determine the maximum number of pump sprays per treatment application. For mild pruritus or for small treatment surface areas, the number of
pumps used should be less than this maximum amount.

Dog Weight / Maximum number of pumps per single application
  • 11 lbs . . . 4 pumps
  • 22 lbs . . . 7 pumps
  • 33 lbs . . . 11 pumps
  • 44 lbs . . . 15 pumps
  • 55 lbs . . . 19 pumps
  • 66 lbs . . . 22 pumps
  • 77 lbs . . . 26 pumps
  • 88 lbs . . . 30 pumps
  • 99 lbs . . . 33 pumps
  • 110 lbs . . . 37 pumps
Using the recommended dosing regime, there are two applications per day for the first week, one application per day for the second week and one application every other day for the last two weeks of treatment.

Federal law (USA) restricts this drug to use by or on the order of a licensed veterinarian

User Safety: Wear gloves when applying the product. Spray in a well ventilated area. If the spray causes irritation to mucous membranes, discontinue use. Keep this and all drugs out of reach of children. Animal Safety: Clinical and experimental data have demonstrated that corticosteroids administered orally or by injection to animals may induce the first stage of parturition if used during the last trimester of pregnancy and may precipitate premature parturition followed by dystocia, fetal death, retained placenta, and metritis. Additionally, corticosteroids administered to dogs, rabbits, and rodents during pregnancy have resulted in cleft palates in offspring. Corticosteroids administered to dogs during pregnancy have also resulted in other congenital anomalies including deformed forelegs, phocomelia, and anasarca.

Precautions: The safety of this product for dogs less than eight pounds or for dogs less than one year of age has not been evaluated. The safety of this product in breeding, pregnant or lactating dogs has not been evaluated. The safety of long term or repeated use of this product (greater than 28 days) has not been evaluated. Prolonged use or overdosage of any corticosteroid may produce adverse effects. Because absorption of triamcinolone acetonide through topical application on the skin and by licking may occur, dogs receiving triamcinolone acetonide therapy should be observed closely for evidence of hypothalamic-pituitary-adrenal (HPA) axis suppression.

When the product was applied at approximately 6 times the maximum allowable dose (100mL) once daily to normal skin of two dogs for five days, plasma cortisol levels were decreased after the first treatment and response to ACTH was reduced. If adverse clinical signs are observed, treatment should be discontinued. Once the signs have disappeared, treatment can be resumed at a lower dose or frequency of application. If hypersensitivity to the product occurs, treatment should be discontinued and appropriate therapy instituted. In the presence of dermatological infections, use of an appropriate antifungal or antibacterial agent should be instituted. If a favorable response does not occur promptly, the corticosteroid should be discontinued until the infection has been adequately controlled.

Store at room temperature, 15° - 30°C (59° - 86°F).

How Supplied: Genesis Topical Spray is supplied in 8 ounce and 16 ounce (478 mL) bottles with spray applicators.

Virbac Animal Health

Rx Medication Sold Only To Licensed Veterinarians & Pharmacies. Current License Must Be On File Prior To Shipping.

Share your knowledge of this product. Be the first to write a review »